Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a…

• Sheela Rao, Naureen Starling, +9 authors Jacqui Oates
• Annals of oncology : official journal of the…
• 2010

BACKGROUND Clinical data showed promising antitumour activity with feasible tolerability for matuzumab plus epirubicin, cisplatin and capecitabine (ECX) chemotherapy in untreated advanced… (More)

Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer.

• Joan Hoff Schiller, Joachim von Pawel, +12 authors Mark A. Socinski
• Journal of thoracic oncology : official…
• 2010

INTRODUCTION This randomized phase II study investigated pemetrexed in combination with the epidermal growth factor receptor (EGFR)-targeting monoclonal antibody matuzumab compared with pemetrexed… (More)

Longterm effects of preoperative carbohydrate loading for colorectal surgery

• Claire Louise Beadman
• 2011

• ‹
• 1
• ›